ReviewBlood reviews2022

SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies.

Bin Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.